Question explored with the scientific record
Conversation so far
- 1 what is the solution for a 74 year old man, healthy otherwise with long covid
- 2 What treatments have evidence specifically for people age 70+?
Answered on this page ↓
What treatments have evidence specifically for people age 70+?
The short version: for a 74-year-old with long COVID, the evidence retrieved does not contain a single treatment study on anyone that age.
The closest match is a randomized trial of creatine in post-viral fatigue, but it enrolled adults 18 to 65, not 70-plus [6]. That trial gave 4 grams of creatine monohydrate daily for six months and found improvements in fatigue, breathing difficulty, body aches, headache, and concentration, with one case of mild nausea [6]. It is the only intervention in the retrieval with a randomized, double-blind, placebo-controlled design, and it is the wrong age group.
Everything else is mechanistic or descriptive. One 2025 review proposes mitochondrial transfer as a therapy for long COVID but flags safety concerns and calls it translational, meaning not ready for patients [2]. Another review argues creatine works by supporting mitochondria, which fits the same mechanism, but again the clinical data is from younger adults [6]. A Korean guideline on post-acute COVID-19 says rehabilitation consistently improves dyspnea, exercise capacity, and fatigue across multiple trials, and that no specific drug has sufficient evidence [15]. That guideline is the most useful practical answer for a 74-year-old: structured rehabilitation, not a pill.
| Intervention | Study design | Age group | Finding |
|---|---|---|---|
| Creatine 4 g/day, 6 months [6] | RCT, double-blind, placebo | 18–65 | Improved fatigue, breathing, aches, concentration |
| Rehabilitation [15] | Guideline, multiple RCTs | All ages | Improves dyspnea, exercise capacity, fatigue |
| Mitochondrial transfer [2] | Review, preclinical | Not applicable | Proposed, safety concerns, not ready |
My call: no treatment in this retrieval has evidence for a 74-year-old. Creatine is the only tested option but studied only up to age 65. Rehabilitation is the safest bet, backed by the guideline, and carries no drug risk. Confidence: low — the age gap is the finding, and the burden of proof for anything else has not been met.
Sources used 26
-
MARKERS OF ACTIVATION AND DYSFUNCTION OF CYTOTOXIC IMMUNE CELLS IN PATIENTS WITH LONG COVID AND DURING AGEING
CD38 and TIM-3 (CD366) expression on cytotoxic lymphocytes reflects immune aging, with long COVID showing patterns suggesting accelerated immunosenescence relative to age-matched controls and elderly individuals.
DOI: 10.25040/ntsh2025.02.12 -
Mitochondrial Dysfunction in Aging, HIV, and Long COVID: Mechanisms and Therapeutic Opportunities
Proposes a unified mitochondrial framework linking aging, HIV, and long COVID by comparing shared mitochondrial dysfunction—ROS, mtDNA damage, mitophagy defects, and metabolic reprogramming—and evaluates emerging organelle-based therapies, notably mitochondrial transfer, while h…
DOI: 10.3390/pathogens14101045 -
Special Issue: Recent Advances in Microglia Research
An editorial overview of five microglia-focused studies—three original research articles and two reviews—covering transcriptional regulation of neuroinflammation (e.g., TonEBP), region-specific microglial responses, in vitro neonatal microglia models, microglia-astrocyte interac…
DOI: 10.3390/ijms26020507 -
Prevalence, Symptoms, and Associated Factors of Long COVID-19: A Cross-Sectional Survey Study
In a Thai hospital cohort of adults with prior COVID-19 infection, long COVID affected about 40% and was most commonly cardiopulmonary and general symptoms, with several factors showing potential (often non-significant) associations including age, obesity, prior infection, and v…
DOI: 10.62691/vmj.2025.273464 -
Prevalence of anti-SARS-CoV-2 IgG positivity and long COVID-19 in pediatric age group
This study investigates the prevalence and associated factors of COVID-19 and long COVID-19 in children aged 5-12 in Duhok province and Zakho city, revealing a high IgG positivity rate of 91.5% and a long COVID-19 prevalence of 4.6%, with significant associations to prior COVID-…
DOI: 10.3855/jidc.19299 -
Creatine as a mitochondrial theranostic in predictive, preventive, and personalized medicine
This mini-review advocates creatine as a mitochondria-targeted theranostic within predictive, preventive, and personalized medicine (PPPM), synthesizing mechanistic evidence of mitochondrial support with clinical data showing diagnostic potential and therapeutic benefits in cond…
DOI: 10.1007/s13167-025-00420-9 -
Age Differences in Becoming COVID Long-Haulers and in Post-Acute Sequelae of SARS-CoV-2
In a nationally representative sample of 608 adults with COVID-19, age was not a significant determinant of post-acute sequelae symptom count or becoming a long-hauler, with about half reporting symptoms three months after diagnosis.
DOI: 10.1093/geroni/igab046.054 -
Post-Pandemic Mental Health: Analyzing Long-Term Effects of COVID-19 on Different Age Groups
COVID-19’s long-term mental health toll varies by age, with children showing anxiety/depression linked to routine disruptions, adults facing burnout and financial stress, and older adults experiencing loneliness and cognitive concerns, underscoring the need for age-tailored ment…
DOI: 10.63056/jllsa.1.1.2025.5 -
Long COVID and Associated Factors Among Chinese Residents Aged 16 Years and Older in Canada: A Cross-Sectional Online Study
A cross-sectional online survey of 491 Chinese residents aged 16+ in Canada found 12.83% reported long COVID, with reinfection, higher COVID-19 symptom severity, and use of traditional Chinese medicine or over-the-counter medicines increasing risk, while very good/good health re…
DOI: 10.3390/biomedicines13040953 -
Neutrophil-to-lymphocyte ratio as a sex-specific predictor of short-term mortality in hospitalised older adults with COVID-19: a pragmatic biomarker of inflammaging in acute vulnerability
A prospective cohort study of 440 older adults (≥65) hospitalized with COVID-19 finds that admission neutrophil-to-lymphocyte ratio (NLR) is a short-term mortality predictor, with a sex-specific stronger association in women, but it does not predict long-term mortality over 3.5 …
DOI: 10.1186/s12979-025-00548-2 -
Characteristics and outcomes of adult patients with asthma presenting with COVID-19: A comparative cohort study
Adults with pre-existing asthma who contracted COVID-19 in Qatar had a lower odds of hospitalization than non-asthmatics, while older age and hypertension predicted hospitalization among asthmatics, and asthma did not significantly affect ICU admission or mortality.
DOI: 10.5339/qmj.2023.15 -
Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients That Should Be Ramped Up Immediately as Key to the Pandemic Crisis
This review argues that hydroxychloroquine plus azithromycin or doxycycline, preferably with zinc, is safe and effective as early outpatient treatment for high-risk COVID-19 patients, citing non-randomized and observational evidence to prevent hospitalization.
DOI: 10.1093/aje/kwaa093 -
Direct and Indirect Effects of COVID-19 on Long-Term Care Residents and Their Family Members
A cross-sectional Israeli study combining quantitative survey data from long-term care facilities with qualitative responses to examine both direct (infection, morbidity, mortality) and indirect (visitation bans, reduced activities, increased use of psychotropic meds) effects of…
DOI: 10.1159/000521146 -
30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study
A single-centre prospective cohort of 233 adults hospitalized with COVID-19 in Milan, Italy during the early epidemic found about 20% 30-day mortality and identified older age, obesity, severity on admission, higher CRP, and elevated CK as independent predictors of death, with w…
DOI: 10.1016/j.phrs.2020.104931 -
Clinical Practice Guideline Recommendations for Post-Acute Sequelae of COVID-19
A Korean Clinical Practice Guideline revision updating evidence-based recommendations for the diagnosis, evaluation, treatment, and prevention of Post-Acute Sequelae of COVID-19 (PASC), emphasizing multidisciplinary care, early antiviral therapy, vaccination to reduce risk, and …
DOI: 10.3947/ic.2025.0151 -
Efficacy of Hydroxychloroquine versus Clarithromycin in the Improvement of Dyspnea and Cough in Patients after the Treatment of Acute-Phase COVID-19
Post-acute COVID-19 patients randomized to hydroxychloroquine, clarithromycin, or placebo for four weeks showed HCQ reducing dyspnea most while clarithromycin best improved cough, but results were limited by small, single-center sample sizes.
DOI: 10.32592/ircmj.2023.25.4.2080 -
Post-Acute COVID-19 Pathophysiology: Cellular Stress Responses, Immune Dysregulation, and Biochemical Signatures in Recovery Phase
The study investigates post-acute COVID-19 pathophysiology by integrating cellular ER stress markers, immune dysregulation, and oxidative/biochemical signatures in recovered patients, revealing persistent cellular stress, pro-inflammatory cytokine elevation, and oxidative imbala…
DOI: 10.33594/000000795 -
Autoantibodies Targeting G-Protein-Coupled Receptors and RAS-Related Molecules in Post-Acute COVID Vaccination Syndrome: A Retrospective Case Series Study
This study presents a retrospective case series of 17 patients who developed post-acute COVID vaccination syndrome (PACVS) characterized by autoantibodies targeting G-protein-coupled receptors and RAS-related molecules, suggesting potential biomarkers for this poorly defined syn…
DOI: 10.3390/biomedicines12122852 -
Clinical and Diagnostic Features of Post-Acute COVID-19 Vaccination Syndrome (PACVS)
This study investigates the clinical and diagnostic features of Post-Acute COVID-19 Vaccination Syndrome (PACVS) in a cohort of 191 individuals, revealing a distinct symptomatology and abnormal blood markers that differentiate PACVS from normal post-vaccination responses.
DOI: 10.3390/vaccines12070790 -
Post-acute COVID-19 syndrome
Post-acute COVID-19 survivors across diverse global cohorts show multi-organ, persistent sequelae—including pulmonary, cardiovascular, neuropsychiatric, renal, and thromboembolic manifestations—underscoring the need for multidisciplinary follow-up care and ongoing research into …
DOI: 10.1038/s41591-021-01283-z -
Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis
This study systematically reviews and meta-analyzes published data to characterize the clinical features of acute and chronic post-COVID syndrome (post-COVID/long-COVID), identifies predictors of syndrome development, and highlights the substantial heterogeneity and generally po…
DOI: 10.1016/j.eclinm.2021.100899 -
COVID-19 and Myocarditis: Review of Clinical Presentations, Pathogenesis and Management
A comprehensive review of how COVID-19, MIS, post-acute COVID-19 syndrome, and vaccination relate to myocarditis, summarizing clinical presentations, proposed pathogenesis, diagnostic approaches, and current management with discussion of limitations and gaps for future research.
DOI: 10.17925/hi.2022.16.1.20 -
CLINICAL ASPECTS OF REPRODUCTIVE-AGE WOMEN WITH MENSTRUAL CYCLE DISORDERS AFTER COVID-19
Post-COVID menstrual disorders in reproductive-age women shift from post-acute COVID, where polymenorrhea/menometrorrhagia predominate, to long COVID, where hyperprolactinemia, thyroid dysfunction and estrogen/progesterone deficiency drive deeper endocrine disruption and likely …
DOI: 10.37699/2308-7005.5.2025.10 -
Imaging Phenotypes of Stress Based on Functional MRI
This study uses resting-state fMRI in 50 post-acute COVID-19 syndrome (PACS) patients and 10 healthy controls to classify imaging-based stress phenotypes, revealing temporal patterns of network involvement (DMN, SALIEN) correlated with PCS-10 scores and suggesting MRI-based phen…
DOI: 10.37191/mapsci-2582-4333-5(1)-127 -
Long COVID-19: Multidisciplinary Approach and Pulmonary Fibrosis Sequelae
Long COVID-19 presents with persistent multisystem symptoms and potential pulmonary fibrosis; multidisciplinary management and rehabilitation are essential to improve quality of life.
DOI: 10.36497/respirsci.v4i3.140 -
Gut Microbiome Signatures During Acute Infection Predict Long COVID
This study investigates the gut microbiome's predictive role during acute SARS-CoV-2 infection in identifying individuals at risk for developing Long COVID, revealing distinct microbiome compositions associated with symptom clusters and demonstrating the microbiome's superior pr…
DOI: 10.1101/2024.12.10.626852